Latest Headlines

  1. PreciseMDX Introduces New End-To-End Digital Health Platform That Automates And Simplifies Diagnostic Testing Experience 8/30/2021

    PreciseMDX, the leading end-to-end digital health platform, introduces a cloud-based solution that automates and simplifies the diagnostic testing experience, empowering labs to deliver a transformative journey to providers and patients.

  2. NIA Acquires PCR Machine, Alexandra Hospital Now Equipped To Do COVID-19 Testing 8/27/2021

    The Nevis Island Administration (NIA) has secured a polymerase chain reaction (PCR) machine that will allow for COVID-19 testing to be carried out at the Alexandra Hospital laboratory on Nevis.

  3. Biodesix DeSoto Laboratory Receives Both ISO 13485:2016 Certification And Accreditation From The College Of American Pathologists 8/25/2021

    Biodesix, Inc. Today Biodesix announced that the Accreditation Committee of the College of American Pathologists (CAP) and British Standards Institute (BSI) on behalf of International Organization for Standardization (ISO) recently awarded both CAP accreditation and ISO 13485:2016 certification to the Biodesix Laboratory located in DeSoto, Kansas, based on results of two independent inspections conducted by CAP and BSI inspectors.

  4. Efficient, Low Maintenance Evaporator 8/25/2021

    Porvair Sciences announces that its Ultravap Mistral XT 150 blowdown evaporator is now able to operate at temperatures up to 80°C thereby significantly increasing the rate of evaporation of both organic solvents and aqueous solutions.

  5. BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform For U.S. Laboratories 8/25/2021

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has launched a new, fully automated high-throughput diagnostic system using robotics and sample management software algorithms to set a new standard in automation for infectious disease molecular testing in core laboratories and other centralized laboratories in the United States.

  6. Accenture Makes Strategic Investment In ixlayer To Expand Access To Virtual Diagnostic Health Testing 8/24/2021

    Accenture has made a strategic investment, through Accenture Ventures, in ixlayer, a provider of technology-based solutions for diagnostic testing. The company’s telehealth platform allows players across the healthcare ecosystem to offer convenient and scalable health testing in a virtual environment.

  7. QIAGEN Reaches Milestone With Its Kits Used To Process More Than Three Billion Biological Samples To Date 8/23/2021

    QIAGEN N.V.  today announced that the number of biological samples processed with consumables kits has passed the three billion mark – a record that underlines its leadership in enabling molecular laboratories to gain valuable insights in research, combatting diseases and forensics.

  8. Todos Medical Completes Validation Of cPass Neutralizing Antibody Blood Test At Provista Diagnostics To Quantify And Monitor Key Biomarkers Of COVID-19 Immunity 8/23/2021

    Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP certified lab Provista Diagnostics has successfully completed the validation studies required to put the cPass Neutralizing Antibody Blood Test into production and expects to launch cPass in September 2021.

  9. Immunexpress Announces SeptiCyte® RAPID Testing For Paediatric Sepsis 8/23/2021

    Immunexpress, Pty Ltd, a molecular diagnostic company founded in Brisbane, today announced that the SeptiCyte® RAPID test will be evaluated in the diagnosis of paediatric sepsis in Queensland children.

  10. Xybion Launches Digital Pathology For Research And Development 8/23/2021

    Xybion Corporation, a global low-code SaaS company that enables digital transformation in highly regulated industries including Life Sciences announced the release of Pristima XD Digital Pathology.